Lurbinectedin, sold under the brand name Zepzelca, is a medication used for the treatment of small cell lung cancer. The most common side effects include...
20 KB (1,473 words) - 22:08, 11 November 2024
survival was 8.5 months. Lurbinectedin showed increased overall survival rate in relapsed small cell lung cancer in a trial. Lurbinectedin is As of 2019[update]...
44 KB (4,353 words) - 22:18, 28 September 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
31 KB (2,908 words) - 06:38, 22 September 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
37 KB (3,397 words) - 01:51, 12 November 2024
Enasidenib L01XX62 Ivosidenib L01XX66 Selinexor L01XX67 Tagraxofusp L01XX69 Lurbinectedin L01XX72 Tazemetostat L01XX73 Sotorasib L01XX74 Belzutifan L01XX75 Tebentafusp...
12 KB (877 words) - 15:36, 25 January 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
61 KB (6,086 words) - 22:34, 7 November 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
31 KB (2,832 words) - 13:30, 20 September 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
14 KB (1,105 words) - 06:03, 14 September 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
20 KB (1,870 words) - 00:52, 30 October 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
18 KB (1,637 words) - 04:59, 12 November 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
15 KB (1,090 words) - 15:26, 1 November 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
15 KB (1,437 words) - 03:54, 17 October 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
18 KB (1,559 words) - 14:08, 31 October 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
20 KB (1,915 words) - 00:12, 31 March 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
92 KB (12,517 words) - 05:38, 1 October 2024
t-MDS/AML". Medscape Reference. WebMD. Retrieved 7 February 2014. "Lurbinectedin", LiverTox: Clinical and Research Information on Drug-Induced Liver...
52 KB (708 words) - 12:37, 26 August 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
9 KB (716 words) - 15:15, 27 October 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
26 KB (2,420 words) - 17:03, 13 November 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
5 KB (324 words) - 12:07, 20 July 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
38 KB (3,966 words) - 22:31, 11 November 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
31 KB (2,796 words) - 07:50, 10 August 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
33 KB (2,959 words) - 02:09, 16 July 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
45 KB (4,765 words) - 15:32, 26 September 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
27 KB (2,575 words) - 15:22, 28 October 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
26 KB (2,647 words) - 17:55, 13 October 2024
Those who relapse are given second-line chemotherapies. Topotecan and lurbinectedin are approved by the US FDA for this purpose. Irinotecan, paclitaxel...
90 KB (9,784 words) - 07:53, 10 October 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
4 KB (128 words) - 11:38, 22 April 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
79 KB (9,506 words) - 22:52, 7 November 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
10 KB (592 words) - 09:07, 13 November 2024
Ivosidenib Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene...
24 KB (2,272 words) - 08:01, 11 November 2024